Timothy Barabe has been appointed executive vice president and chief financial officer of Affymetrix. Barabe replaced outgoing CFO John Batty, who resigned last week.
Barabe joins Affy from Human Genome Sciences, where he served as CFO since 2006. Before that, he held the same position at Regent Medical.
Barabe holds an MBA in finance from the University of Chicago and a BBA in finance from the University of Massachusetts.
Barabe's predecessor Batty served at Affy for three years.
The company said in a filing with the US Securities and Exchange Commission that Barabe will receive a base salary of $380,000 per year and will be eligible for an annual bonus at a target level equal to 50 percent of his base salary.
Fredrik Dahl has been appointed chief technology officer at Olink Genomics, the firm said this week.
Dahl will lead the company's R&D efforts, with focus on developing its Selector Technology and related products.
Before joining Uppsala, Sweden-based Olink, Dahl held senior R&D positions in next-generation sequencing startups Complete Genomics and Ion Torrent Systems. He did his postdoc at the Stanford Genome Technology Center under the supervision of Ronald Davis.